Company: CYTK
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001193125-25-267059
Chunk: 0

Company: CYTOKINETICS INC
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
CYTOKINETICS, INCORPORATED 

CONDENSED CONSOLIDATED BALANCE SHEETS 

(In thousands) (Unaudited)

     September 30, 2025

     December 31, 2024

     ASSETS

     Current assets:

     Cash and cash equivalents
      
     $
     225,467

     $
     94,857

     Short-term investments

     737,068

     981,157

     Accounts receivable

     1,808

     16,650

     Prepaid expenses and other current assets

     13,006

     15,276

     Total current assets

     977,349

     1,107,940

     Long-term investments

     288,817

     145,055

     Property and equipment, net

     76,001

     65,815

     Operating lease right-of-use assets

     77,580

     75,158

     Other assets

     16,810

     7,705

     Total assets
      
     $
     1,436,557

     $
     1,401,673

     LIABILITIES AND STOCKHOLDERS’ DEFICIT

     Current liabilities:

     Accounts payable
      
     $
     22,084

     $
     20,369

     Accrued liabilities

     61,633

     55,323

     Short-term operating lease liabilities

     20,647

     18,978

     Current portion of long-term debt

     17,280

     11,520

     Derivative liabilities measured at fair value

     16,900

     11,300

     Deferred revenue

     1,612

     52,370

     Other current liabilities

     1,988

     9,814

     Total current liabilities

     142,144

     179,674

     Term loans, net

     158,747

     93,227

     Convertible notes, net

     889,524

     552,370

     Liabilities related to revenue participation right purchase agreements, net

     504,498

     462,192

     Long-term operating lease liabilities

     110,655

     112,582

     Liabilities related to RPI Transactions measured at fair